APIS · Insurance and Treatment Access

Insurance and Treatment Access

If proton therapy is denied, authorization is pending or access is delayed, you can explore Korean hospital review while the insurance process continues. Ask your treating team how soon treatment should begin and what care is available now. An insurance appeal decides coverage; the Korean hospital reviews treatment options.

Proton Therapy Insurance Denied

Request the written reason for denial and the appeal deadline. Ask your treating doctor why proton therapy was recommended and what other treatment could be used.

  • Check which clinical records or medical explanation the insurer needs.
  • Ask whether an expedited review is available when a delay could harm your health.
  • Continue the appeal and explore a Korean hospital review in parallel if useful.

A denial does not settle the medical question. Your treating team can explain the risks of waiting and the available alternatives. HealthCare.gov explains internal appeals and external review.

Prior Authorization Pending

While authorization is pending, clarify the treatment deadline and what the insurer still needs.

  • When should treatment start, and how long is it medically reasonable to wait?
  • What information is missing, and who will provide it?
  • Is an urgent review available under the plan?
  • What treatment is available if approval is delayed?
  • Can Korean hospital review proceed alongside your current care?

Appeals and Korean Hospital Review

Insurance appeal Korean hospital review
Decides whether the insurer will cover the requested care. Reviews whether the hospital can offer treatment for the case.
Follows the insurer’s requirements and appeal deadlines. Uses the receiving hospital’s requested records, consultation process and scheduling.

These processes can run together. Korean hospital acceptance does not mean that an insurer will pay for overseas care; check that separately with the insurer.

Delayed Treatment Access

Insurance authorization, provider networks, waiting times and local treatment availability can affect access. Ask the treating team which delays are medically acceptable and whether another local treatment should begin.

Do not postpone necessary care while seeking another opinion. When other treatment or local care may be more appropriate explains situations where travel for particle therapy may be unsafe or unhelpful.

Parallel Korean Hospital Review

APIS can coordinate a Korean review while your insurance process continues. Keep the treating team informed so a review abroad does not disrupt necessary current care.

Starting an inquiry and preparing hospital records

Hospital Estimates and Overseas Coverage

Confirm overseas coverage directly with your insurer. Treatment Time and Cost explains how to compare your actual liability at home with a Korean estimate and travel costs.

For a separate question about where carbon-ion treatment is operating, see U.S. Carbon-Ion Availability.

Explore a Parallel Review

Keep the clinical treatment deadline in view while coverage questions are resolved.

Sources and dates
  1. HealthCare.gov: appealing an insurance-company decision. U.S. insurance appeal overview; undated The plan’s rules and notices govern the appeal.
  2. Mayo Clinic Radiation Oncology overview. Carbon-ion program status the linked APIS availability page maintains the timeline.

Content reviewed October 23, 2026.

Your request has been received.
We will review the submitted information and contact you by email if additional details are required.​